ReviewDrugs2025
Iparomlimab and Tuvonralimab: First Approval.
Susan J KeamPubMed ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papertrialcites it
ReviewDrugs2025
Susan J KeamPubMed ↗Publisher ↗
No numbers read from the abstract.